BMJ: British Medical Journal; 3/9/2024, Vol. 384 Issue 8420, p370-373, 4p
Subject
THERAPEUTIC use of antineoplastic agents PNEUMONIA treatment MELANOMA diagnosis THERAPEUTIC use of monoclonal antibodies CONTINUING education units INTRAVENOUS immunoglobulins FEAR PALLIATIVE treatment DRUG side effects HEMOPHAGOCYTIC lymphohistiocytosis MELANOMA DEATH HEALTH status indicators LIFE expectancy IMMUNOTHERAPY JAUNDICE GENE rearrangement CATASTROPHIC illness NAPROXEN UNCERTAINTY CANCER chemotherapy GENES IMMUNE checkpoint inhibitors PANCREATIC tumors HIP joint ROUTINE diagnostic tests SOCIAL integration QUALITY of life HORMONE therapy PAIN OPIOID analgesics RENAL cell carcinoma SPIRITUALITY COMMUNICATION SOCIAL support TUMORS GENETIC mutation DYSPNEA LUNG cancer DISEASE progression FENTANYL